Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × alectinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Hematologic Neoplasms 2 Solid Tumors 1 Sexual Dysfunction, Physiological 1 Rare Tumor 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Lymphoproliferative Disorders 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Diseases 1 Eunuchism 1 Erectile Dysfunction 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1

Interventions

Radiosurgery 23 Magnetic Resonance Spectroscopy 18 pembrolizumab 10 Temozolomide 10 Specimen Handling 8 Bevacizumab 8 Radiotherapy 5 Nivolumab 5 Magnetic Resonance Imaging 5 Ipilimumab 5 Cyclophosphamide 5 Neuropsychological Tests 4 Carboplatin 4 Capecitabine 4 fludarabine 3 fluciclovine F-18 3 encorafenib 3 abemaciclib 3 Radiation 3 Proton Therapy 3 Mental Status and Dementia Tests 3 Etoposide 3 Dexamethasone 3 Blood Specimen Collection 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 osimertinib 2 niraparib 2 binimetinib 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05987644 2026-03-09

DURABLE

Hoosier Cancer Research Network

Phase 1/2 Recruiting

Brain Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡